Vanessa's Comment:

This new Phase 1 sonodynamic therapy trial for recurrent GBM is sponsored by the Focused Ultrasound Foundation and will leverage the NaviFUS neuronavigation-guided focused ultrasound system together with 5-ALA. The trial is being conducted at University of Virginia Health System and plans to enroll up to 11 patients. 

---

Posted on: 03/28/2024

First Participant Receives Sonodynamic Therapy for Glioblastoma in New Clinical Trial

 

---

Click HERE to return to brain tumor news headlines.